Asset management firm Strive Inc. today announced a merger with health tech firm Semler Scientific to create a new Bitcoin (BTC) treasury company that will hold more than 10,000 BTC on its balance sheet.
In addition, Strive announced the acquisition of 5,816 BTC – purchased for a total of $675 million – at $116,047 per coin. Today’s purchase has increased Strive’s total BTC holdings significantly, pushing them to 5,886 BTC.
The merger deal with Semler Scientific represents an approximately 210% premium, equivalent to roughly $90.52 per share. These estimates are based on the trading price of Semler Scientific common stock and Strive Class A common stock as of September 19.
Essentially, each common share of Semler Scientific will be swapped for 21.05 Class A shares of Strive. Notably, Strive aimed to avoid debt-maturity risk, and subsequently pitched a “preferred equity-only” model. The company added that it aims to grow BTC per share faster than the spot BTC price.
Notably, the newly created company will hold more than 10,900 BTC on its balance sheet. While Strive made its first major BTC purchase just before the merger, Semler Scientific has been a fairly established name when it comes to companies that have adopted a Bitcoin treasury strategy.
According to data from Coingecko, Semler Scientific ranked 18th on the list of public companies that hold BTC on their balance sheets. However, following today’s announcement, the new firm could rank 13th in the updated list, behind the likes of Coinbase and Tesla.
The merger between Strive Inc., and Semler Scientific has already been approved by the boards of directors of both firms. Commenting on the development, Matt Cole, Chairman and CEO, Strive, said:
This merger cements Strive’s position as a top Bitcoin treasury company, and we believe our alpha-seeking strategies and capital structure position us to outperform Bitcoin over the long run. This transaction showcases how we can grow Bitcoin holdings and Bitcoin per share at an unmatched pace in the industry to drive equity value accretion.